Overall, our model predicts that CBX3 is required for fine-tuning the expression of IFNγ-stimulated immune genes, which makes CBX3 implicated in modulating colon inflammatory response as well as colon cancer chemo-resistance. This evidence concerns the gene CBX3 and malignant colon neoplasm.